ceftazidime mip
mip pharma gmbh - ceftazidimas - milteliai injekciniam ar infuziniam tirpalui - 1 g; 2 g - ceftazidime
flixotide
glaxosmithkline trading services limited - flutikazonas - suslėgtoji įkvepiamoji suspensija - 250 µg/dozėje; 125 µg/dozėje; 50 µg/dozėje - fluticasone
flixotide diskus
glaxosmithkline trading services limited - flutikazonas - dozuoti įkvepiamieji milteliai - 500 µg/dozėje; 250 µg/dozėje; 50 µg/dozėje; 100 µg/dozėje - fluticasone
fortum
glaxosmithkline lietuva, uab - ceftazidimas pentahidratas - milteliai injekciniam ar infuziniam tirpalui - 2 g; 1 g; 3 g; 500 mg - ceftazidime
fetcroja
shionogi b.v. - cefiderocol sulfatas tozilatas - gram-neigiamų bakterijų infekcijos - antibacterials sisteminio naudojimo, - fetcroja fluorouracilu ir folino infekcijų dėl aerobinių gram-neigiamų organizmų suaugusiųjų, turinčių ribotos gydymo galimybės (žr. skirsnius 4. 2, 4. 4 ir 5. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.
bimzelx
ucb pharma s.a. - bimekizumab - psoriazė - imunosupresantai - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
ceftazidime qilu
qilu pharma spain s.l. - ceftazidimas - milteliai injekciniam ar infuziniam tirpalui - 1 g - ceftazidime
fluconazole actavis
actavis group ptc ehf. - flukonazolas - kietosios kapsulės - 200 mg; 150 mg; 100 mg; 50 mg - fluconazole
diflazon
krka, d.d., novo mesto - flukonazolas - infuzinis tirpalas - 2 mg/ml; 200 mg; 150 mg; 100 mg; 50 mg - fluconazole
lomexin
lex ano, uab - fentikonazolo nitratas - makšties minkštosios kapsulės - 600 mg; 200 mg - fenticonazole